search
Back to results

Metacognitive-Strategy Training in Sub-Acute Stroke

Primary Purpose

Stroke

Status
Recruiting
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Usual Care Occupational Therapy-Outpatient
Cognitive Orientation to daily Occupational Performance
Sponsored by
University of Missouri-Columbia
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stroke focused on measuring Stroke, Occupational therapy, Rehabilitation, Participation

Eligibility Criteria

50 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • less than 9 months post-stroke
  • adults age 40-85
  • completed inpatient rehabilitation services (if recommended)
  • living in the community with or without caregiver support (i.e., not living in a skilled nursing facility)
  • ability to read, write, and speak English
  • self-identified activity performance goals per the Canadian Occupational Performance Measure (COPM)
  • upper extremity hemiparesis as indicated by a score of 1-3 on the NIHSS motor arm score, documented in acute therapy evaluation, and/or per self- report of the participant.
  • absence of moderate or severe aphasia as indicated by a National Institutes of Health Stroke Scale (NIHSS) aphasia score of 1 or less or documented in acute therapy evaluation

Exclusion Criteria:

  • inability to provide informed consent
  • severe depressive symptoms as indicated by a score >21 on the Patient Health Questionnaire (PHQ-9)
  • dementia symptoms as indicated by a score of <23 on the Montreal Cognitive Assessment (MoCA)
  • additional neurological diagnoses identified by medical chart review (e.g., brain malignancy)
  • no voluntary movement in affected upper extremity as indicated by a score of 4 on the NIHSS motor arm score or documented in acute therapy evaluation
  • anosognosia as indicated by an inability to identify activity performance problems on the COPM
  • any other condition not otherwise specified that the PI determines would render participation in this study as unsafe
  • any medical condition that the medial monitor determines would render participation in this study as unsafe

Sites / Locations

  • University of Missouri: Department of Occupational TherapyRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Usual Care Occupational Therapy-Outpatient

Cognitive Orientation to daily Occupational Performance

Arm Description

Outcomes

Primary Outcome Measures

Canadian Occupational Performance Measure (COPM)
The COPM is a semi-structured interview guide for establishing a subject's activity performance levels within self-care, leisure, and productivity. The subject will set a minimum of 5 activity goals, providing a self-rating of 1-10 for level of performance and satisfaction with performance on each. An average score across goals for performance and satisfaction will be used in analysis
Performance Quality Rating Scale (PQRS)
The PQRS is an observational, objective method of scoring subject activity performance of goals set via the COPM. A blind, trained rater external to the research study team will view video recordings of each subject performing goals. Each goal is rated on a scale of 1 (no activity criteria were met) to 10 (all activity criteria were met). The final score used in the analysis will be an average of all 5 goals.
The Life Space Questionnaire
The Life Space Questionnaire is a self-reported measure of community mobility and social participation. It is comprised of 9 yes/no questions related to places visited in the previous three days. Total number of "yes" responses (range 0-9) will be used in the analysis.
Upper Extremity Fugl-Meyer
The Fugl-Meyer is a well-established measure of upper extremity motor performance in individuals with post-stroke hemiparesis. Each item is scored either a 0 (cannot perform), 1 (performs partially), or 2 (performs fully) with a maximum score of 66. In the present study, the upper extremity scaled scored will be used in analysis.

Secondary Outcome Measures

Patient Health Questionnaire (PHQ-9)
The PHQ-9 is a self-report measure of depressive symptoms. The subject identifies how often over the previous 2 weeks they have experienced 9 depressive symptoms. The total score reflects the severity of depressive symptoms. A score of 21 or greater indicates severe depressive symptoms. Total score will be used in analysis.
NIH Toolbox (NIH-TB)-Cognition Battery
The NIH-TB will be used to evaluate subjects' crystallized intelligence. In contrast to the primary outcome of fluid intelligence, crystalized intelligence is more dependent upon previous learning experience. A crystalized intelligence composite T-score and fluid intelligence T-score will be used in analysis
Stroke Impact Scale (SIS)
The SIS is a self-report measure of stroke recovery. Specifically, the measure assesses physical, cognitive, psychosocial, community mobility, and general activity performance on a 5 point Likert scale. There is an additional item for overall recovery rated on a scale of 0 (no recovery) to 100 (full recovery). Domain scores will be used in analysis.
Patient-Reported Outcomes Measurement Information System (PROMIS): Satisfaction with Social Roles and Activities (Item Bank v2.0)
The PROMIS Satisfaction with Social Roles and Activities item bank assesses satisfaction with performing one's usual social roles and activities. The T-score for this assessment will be used in the analysis.

Full Information

First Posted
September 19, 2019
Last Updated
May 17, 2023
Sponsor
University of Missouri-Columbia
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Michigan
search

1. Study Identification

Unique Protocol Identification Number
NCT04099511
Brief Title
Metacognitive-Strategy Training in Sub-Acute Stroke
Official Title
Efficacy of Metacognitive-Strategy Training to Improve Activity Performance and Reduce Motor Impairment in Sub-Acute Stroke
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 21, 2019 (Actual)
Primary Completion Date
March 30, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Missouri-Columbia
Collaborators
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), University of Michigan

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The long-term goal of this research is to improve activity performance and reduce motor impairment in individuals with stroke. Contemporary stroke rehabilitation focuses on remediation of post-stroke impairments with a false assumption that reduction in impairments will automatically lead to improvements in activity performance. Specifically, stroke rehabilitation is focused primarily on the use of task-specific training (TST), which recent research has found to yield negligible improvement in upper extremity motor function often consistent with or less than control conditions. These protocols are time intensive and often do not lead to transfer of training effects to improvement in activity performance. This is a common issue that has been evidenced in longitudinal studies of individuals with stroke; over half of stroke survivors continue to be dependent on others for the most basic of life activities after rehabilitation. Decreases in activity performance further contribute to lower life satisfaction, quality of life, and participation in daily life. The goal of this proposed project is to evaluate the efficacy of a clinically-feasible metacognitive strategy training (MCST) intervention, the Cognitive Orientation to daily Occupational Performance (CO-OP) approach, to improve activity performance and reduce stroke impairment for individuals with sub-acute stroke. Recent evidence highlights two primary issues in stroke rehabilitation. 1) Interventions are needed that directly target activity performance. Gains in upper extremity function, even using the most contemporary approaches, are not translating to meaningful gains in activity performance. 2) Interventions need to be clinically feasible for future implementation. In recent stroke rehabilitation clinical trials, participants received an average of over 30 hours of therapy in only one treatment modality. Individuals in stroke rehabilitation receive a median of only 6 outpatient visits across all health care specialties combined (OT, PT, SLP, physiatrist). Metacognitive strategy training (MCST), specifically the Cognitive Orientation to daily Occupational Performance (CO-OP) approach, is a potential solution to address both of these gaps. CO-OP is a performance-based, problem-solving approach that enables participants to improve task performance through cognitive strategy use. In the exploratory clinical trial for individuals with sub-acute stroke (n=26), the study compared ten, 45-minute sessions of MCST (CO-OP) with dose-matched outpatient usual care outpatient occupational therapy (OT). The MCST (CO-OP) group demonstrated a large effect over usual care on objective measures of trained functional activities (d=1.6) and untrained functional activities (d = 1.1). The MCST group also demonstrated a moderate effect over usual care outpatient OT on improving motor function (r = 0.3). The goal of this proposed project is to determine the efficacy of MCST to improve activity performance and to reduce motor impairments in individuals with subacute stroke. A single-blind, parallel, randomized clinical trial will be conducted with individuals with sub-acute stroke. Participants will be randomized to a 10-session MCST (CO-OP) treatment group or to a dose matched usual care outpatient OT control group. Data will be collected pre-intervention, post-intervention, and at 3-months post-intervention assessment. Our central research hypothesis is that MCST will produce a significant improvement on objective and subjective measures of activity performance (trained and untrained goals) and reduce motor impairment in comparison to a usual care OT group. Objective 1: Evaluate the efficacy of MCST to improve subjective and objective activity performance in individuals with subacute stroke. Primary Endpoint: MCST will have a greater positive effect compared to usual care OT on subjective and objective activity performance of trained goals. Primary Endpoint: MCST will have a greater positive effect compared to usual care OT on subjective and objective activity performance of untrained activity goals to demonstrate transfer of the treatment effect. Secondary Endpoint: MCST will have a greater positive effect compared to usual care OT on subjective stroke recovery (participation and role functioning) Objective 2: Evaluate the efficacy of MCST to improve motor function in individuals with subacute stroke. Primary Endpoint: MCST group will have a greater positive effect compared to usual care OT on reducing motor impairment. Secondary Endpoint: MCST will have a greater positive effect compared to usual care OT on subjective stroke recovery (physical functioning)

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stroke
Keywords
Stroke, Occupational therapy, Rehabilitation, Participation

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Model Description
A single-blind, parallel, randomized clinical trial design will be used in this study. Randomization will be conducted using stratified randomization. Randomization will be stratified by age (50-68 v 69-85) and stroke severity (NIHSS total score 1-16 v >16). Within each strata randomization will be blocked to help ensure an equal number of participants have been assigned to each intervention group.
Masking
Outcomes Assessor
Masking Description
Blind raters will be used to collect all outcomes measures
Allocation
Randomized
Enrollment
108 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Usual Care Occupational Therapy-Outpatient
Arm Type
Active Comparator
Arm Title
Cognitive Orientation to daily Occupational Performance
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
Usual Care Occupational Therapy-Outpatient
Intervention Description
The control group in the proposed study will receive usual care occupational therapy services. The dosage between the experimental group and usual care will be identical with each group receiving ten 45- minute treatment sessions. The treating therapists will be unfamiliar with the experimental group intervention to avoid contamination. Each therapist will be instructed to provide care in the same manner as they typically provide in day-to-day practice for patients with similar characteristics as those in the study. The therapists will be encouraged to provide home action plans to participants. Usual care services will be monitored through a log of number of sessions, time spent in each session, and what activities were the focus of each session. The therapists will be instructed that they can address any participant goals they wish other than transfer goals identified by the participant.
Intervention Type
Behavioral
Intervention Name(s)
Cognitive Orientation to daily Occupational Performance
Intervention Description
The Cognitive Orientation to daily Occupational Performance (CO-OP) approach was developed within the field of occupational therapy and is a performance-based, problem-solving approach to address activity performance limitations. Subjects will be taught to use the global problem-solving strategy of Goal-Plan-Do-Check: identifying a specific goal (Goal), outlining a practical plan for reaching that goal (Plan), accurately performing the plan (Do), and analyzing whether the plan led to achievement of the goal and altering the plan accordingly (Check). The Goal-Plan-Do-Check process will be iteratively applied to each of the activity goals. Therapists will use guided discovery to allow the subject to self-identify their own potential solutions within an activity (develop the plan). The therapists will be instructed that they can address any participant goals they wish other than transfer goals identified by the participant.
Primary Outcome Measure Information:
Title
Canadian Occupational Performance Measure (COPM)
Description
The COPM is a semi-structured interview guide for establishing a subject's activity performance levels within self-care, leisure, and productivity. The subject will set a minimum of 5 activity goals, providing a self-rating of 1-10 for level of performance and satisfaction with performance on each. An average score across goals for performance and satisfaction will be used in analysis
Time Frame
Change in baseline to follow-up (12 weeks after post-intervention assessment)
Title
Performance Quality Rating Scale (PQRS)
Description
The PQRS is an observational, objective method of scoring subject activity performance of goals set via the COPM. A blind, trained rater external to the research study team will view video recordings of each subject performing goals. Each goal is rated on a scale of 1 (no activity criteria were met) to 10 (all activity criteria were met). The final score used in the analysis will be an average of all 5 goals.
Time Frame
Change in baseline to follow-up (12 weeks after post-intervention assessment)
Title
The Life Space Questionnaire
Description
The Life Space Questionnaire is a self-reported measure of community mobility and social participation. It is comprised of 9 yes/no questions related to places visited in the previous three days. Total number of "yes" responses (range 0-9) will be used in the analysis.
Time Frame
Change in baseline to follow-up (12 weeks after post-intervention assessment)
Title
Upper Extremity Fugl-Meyer
Description
The Fugl-Meyer is a well-established measure of upper extremity motor performance in individuals with post-stroke hemiparesis. Each item is scored either a 0 (cannot perform), 1 (performs partially), or 2 (performs fully) with a maximum score of 66. In the present study, the upper extremity scaled scored will be used in analysis.
Time Frame
Change in baseline to follow-up (12 weeks after post-intervention assessment)
Secondary Outcome Measure Information:
Title
Patient Health Questionnaire (PHQ-9)
Description
The PHQ-9 is a self-report measure of depressive symptoms. The subject identifies how often over the previous 2 weeks they have experienced 9 depressive symptoms. The total score reflects the severity of depressive symptoms. A score of 21 or greater indicates severe depressive symptoms. Total score will be used in analysis.
Time Frame
Change in baseline to follow-up (12 weeks after post-intervention assessment)
Title
NIH Toolbox (NIH-TB)-Cognition Battery
Description
The NIH-TB will be used to evaluate subjects' crystallized intelligence. In contrast to the primary outcome of fluid intelligence, crystalized intelligence is more dependent upon previous learning experience. A crystalized intelligence composite T-score and fluid intelligence T-score will be used in analysis
Time Frame
Change in baseline to follow-up (12 weeks after post-intervention assessment)
Title
Stroke Impact Scale (SIS)
Description
The SIS is a self-report measure of stroke recovery. Specifically, the measure assesses physical, cognitive, psychosocial, community mobility, and general activity performance on a 5 point Likert scale. There is an additional item for overall recovery rated on a scale of 0 (no recovery) to 100 (full recovery). Domain scores will be used in analysis.
Time Frame
Change in baseline to follow-up (12 weeks after post-intervention assessment)
Title
Patient-Reported Outcomes Measurement Information System (PROMIS): Satisfaction with Social Roles and Activities (Item Bank v2.0)
Description
The PROMIS Satisfaction with Social Roles and Activities item bank assesses satisfaction with performing one's usual social roles and activities. The T-score for this assessment will be used in the analysis.
Time Frame
Change in baseline to follow-up (12 weeks after post-intervention assessment)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
50 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: less than 9 months post-stroke adults age 40-85 completed inpatient rehabilitation services (if recommended) living in the community with or without caregiver support (i.e., not living in a skilled nursing facility) ability to read, write, and speak English self-identified activity performance goals per the Canadian Occupational Performance Measure (COPM) upper extremity hemiparesis as indicated by a score of 1-3 on the NIHSS motor arm score, documented in acute therapy evaluation, and/or per self- report of the participant. absence of moderate or severe aphasia as indicated by a National Institutes of Health Stroke Scale (NIHSS) aphasia score of 1 or less or documented in acute therapy evaluation Exclusion Criteria: inability to provide informed consent severe depressive symptoms as indicated by a score >21 on the Patient Health Questionnaire (PHQ-9) dementia symptoms as indicated by a score of <23 on the Montreal Cognitive Assessment (MoCA) additional neurological diagnoses identified by medical chart review (e.g., brain malignancy) no voluntary movement in affected upper extremity as indicated by a score of 4 on the NIHSS motor arm score or documented in acute therapy evaluation anosognosia as indicated by an inability to identify activity performance problems on the COPM any other condition not otherwise specified that the PI determines would render participation in this study as unsafe any medical condition that the medial monitor determines would render participation in this study as unsafe
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Samantha Shea-Lemoins, BS
Phone
573-882-6879
Email
sheasn@health.missouri.edu
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Timothy J Wolf, OTD, PhD
Organizational Affiliation
University of Missouri-Columbia
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Missouri: Department of Occupational Therapy
City
Columbia
State/Province
Missouri
ZIP/Postal Code
65211
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Meredith Spiers, MA
Phone
573-882-7085
Email
spiersme@health.missouri.edu
First Name & Middle Initial & Last Name & Degree
Timothy Wolf, OTD, PhD

12. IPD Sharing Statement

Plan to Share IPD
Yes
IPD Sharing Plan Description
All de-identified clinical outcome assessment data with accompanying key will be deposited in MOspace Institutional Repository, the University of Missouri's digital institutional repository. MOspace is based on MIT's DSpace technology and is a joint venture of the University of Missouri's Division of Information Technology and the University Libraries. MOspace items will include appropriate metadata and a permanent URL. Items will be freely available via the MOspace web site and will be searchable via Google and other search engines.
IPD Sharing Time Frame
After completion of study and publication of primary results manuscript. The data will be available indefinitely.
IPD Sharing URL
https://mospace.umsystem.edu/xmlui/

Learn more about this trial

Metacognitive-Strategy Training in Sub-Acute Stroke

We'll reach out to this number within 24 hrs